Is mortality a useful primary endpoint for critical care trials?
Mortality has long been used as a primary endpoint for randomized controlled trials in critical care. Recently, a plurality of trials targeting mortality endpoints as their primary outcome have failed to detect a difference between study arms. While there are a number of reasons for the preponderance of such neutral trials, the use of mortality as an outcome is one important consideration. We explore some of the reasons why such trials may be biased towards a neutral result, as well as reasons to consider alternative endpoints that are better coupled to the expected therapeutic effect. We also discuss to what extent mortality as a binary outcome is patient-important in the intensive care unit.